An AP Perspective on Infusion Reactions in the Era of Immunotherapy

As cancer care advances, creative uses for immunotherapy continue to be developed, but it is also important to be cognizant of the risk for infusion reactions. At JADPRO Live Virtual 2021, Carrie Peterson, DNP, RN, AGNP-c, reviewed the different classes and pathophysiology of immunotherapy, how to a...

Descripción completa

Detalles Bibliográficos
Autor principal: Peterson, Carrie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Harborside Press LLC 2022
Materias:
Meeting Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126347/
https://www.ncbi.nlm.nih.gov/pubmed/35663179
http://dx.doi.org/10.6004/jadpro.2022.13.3.13
_version_ 1784712107428675584
author Peterson, Carrie
author_facet Peterson, Carrie
author_sort Peterson, Carrie
collection PubMed
description As cancer care advances, creative uses for immunotherapy continue to be developed, but it is also important to be cognizant of the risk for infusion reactions. At JADPRO Live Virtual 2021, Carrie Peterson, DNP, RN, AGNP-c, reviewed the different classes and pathophysiology of immunotherapy, how to anticipate potential infusion reactions for each class of immunotherapy, and how to identify and treat infusion reactions during infusion of immunotherapy so that patients can stay on treatment.
format Online
Article
Text
id pubmed-9126347
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Harborside Press LLC
record_format MEDLINE/PubMed
spelling pubmed-91263472022-06-04 An AP Perspective on Infusion Reactions in the Era of Immunotherapy Peterson, Carrie J Adv Pract Oncol Meeting Reports As cancer care advances, creative uses for immunotherapy continue to be developed, but it is also important to be cognizant of the risk for infusion reactions. At JADPRO Live Virtual 2021, Carrie Peterson, DNP, RN, AGNP-c, reviewed the different classes and pathophysiology of immunotherapy, how to anticipate potential infusion reactions for each class of immunotherapy, and how to identify and treat infusion reactions during infusion of immunotherapy so that patients can stay on treatment. Harborside Press LLC 2022-04 2022-05-23 /pmc/articles/PMC9126347/ /pubmed/35663179 http://dx.doi.org/10.6004/jadpro.2022.13.3.13 Text en © 2022 Harborside™ https://creativecommons.org/licenses/by-nc-nd/3.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial Non-Derivative License, which permits unrestricted non-commercial and non-derivative use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Reports
Peterson, Carrie
An AP Perspective on Infusion Reactions in the Era of Immunotherapy
title An AP Perspective on Infusion Reactions in the Era of Immunotherapy
title_full An AP Perspective on Infusion Reactions in the Era of Immunotherapy
title_fullStr An AP Perspective on Infusion Reactions in the Era of Immunotherapy
title_full_unstemmed An AP Perspective on Infusion Reactions in the Era of Immunotherapy
title_short An AP Perspective on Infusion Reactions in the Era of Immunotherapy
title_sort ap perspective on infusion reactions in the era of immunotherapy
topic Meeting Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9126347/
https://www.ncbi.nlm.nih.gov/pubmed/35663179
http://dx.doi.org/10.6004/jadpro.2022.13.3.13
work_keys_str_mv AT petersoncarrie anapperspectiveoninfusionreactionsintheeraofimmunotherapy
AT petersoncarrie apperspectiveoninfusionreactionsintheeraofimmunotherapy

Ejemplares similares